Publications en collaboration avec des chercheurs de Hospital Clínico San Carlos de Madrid (18)

2024

  1. Efficacy of delafloxacin alone and in combination with cefotaxime against cefotaxime non-susceptible invasive isolates of Streptococcus pneumoniae

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 158-162

2023

  1. High performance of the automated ADVIA Centaur Systems SARS-CoV-2 Antigen Assay in nasopharyngeal samples with high viral load

    International Microbiology, Vol. 26, Núm. 3, pp. 471-474

  2. High rates of colonization by Staphylococcus aureus in medical students before doing their clinical practices

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 4, pp. 251-253

2022

  1. Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose

    Vaccines, Vol. 10, Núm. 9

  2. Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli

    Medical Microbiology and Immunology, Vol. 211, Núm. 5-6, pp. 269-272

2020

  1. Increase of serotype 8, ST53 clone, as the prevalent strain of Streptococcus pneumoniae causing invasive disease in Madrid, Spain (2012–2015)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 3, pp. 105-110

2018

  1. Identification of Streptococcus pneumoniae lytA, plyA and psaA genes in pleural fluid by multiplex real-time PCR

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 7, pp. 428-430

2017

  1. Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing enterobacteriaceae

    Journal of Medical Microbiology, Vol. 66, Núm. 2, pp. 169-174

  2. In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 2, pp. 191-196

  3. Plazomicin activity against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates in relation to aminoglycoside-modifying enzymes

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2

2015

  1. Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates

    Microbial Drug Resistance

2014

  1. Recurrent pneumococcal invasive disease in the Region of Madrid during a five-year period

    Infection, Vol. 42, Núm. 3, pp. 475-483

2013

  1. Rapid diagnosis of invasive pneumococcal disease in pediatric population

    Journal of Microbiological Methods, Vol. 93, Núm. 2, pp. 116-120

2011

  1. Clonal spread of levofloxacin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain, 2007 to 2009

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 5, pp. 2469-2471

  2. Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in madrid

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 6, pp. 471-474

  3. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar

    Clinical and Vaccine Immunology, Vol. 18, Núm. 1, pp. 89-94

2010

  1. Direct serogrouping of Streptococcus pneumoniae strains in clinical samples by use of a latex agglutination test

    Journal of Clinical Microbiology, Vol. 48, Núm. 2, pp. 593-595

  2. High percentage of resistance to ciprofloxacin and qnrB19 gene identified in urinary isolates of extended-spectrum β-lactamase-producing Escherichia coli in Madrid, Spain

    Diagnostic Microbiology and Infectious Disease, Vol. 67, Núm. 4, pp. 380-383